Luca Toschi
IRCCS Humanitas Research Hospital · 147 works · 6,122 citations · h-index 35
Top works
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- IncreasedHER2Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients
- Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
- Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial
- Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
- MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
- Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
- Role of gemcitabine in cancer therapy
- First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status
- 989P Sotorasib in advanced KRAS p.G12C-mutated non-small cell lung cancer (NSCLC): Safety and efficacy data from the global expanded access program (EAP)
- HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients
- Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery
- Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
- EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)
- PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.
- Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
- Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
- Clinical Implications of MET Gene Copy Number in Lung Cancer
- Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)
- Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients